|
| 36610526 | SGK1 inhibition attenuates the action potential duration in reengineered heart cell models of drug-induced QT prolongation. | Heart Rhythm | 2023 |
| 37099628 | Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2. | Europace | 2023 |
| 35182037 | A Phase 1 Clinical Study Evaluating the Effects of Cenobamate on the QT Interval. | Clin Pharmacol Drug Dev | 2022 |
| 36441560 | First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301). | Circ Arrhythm Electrophysiol | 2022 |
| 34144104 | Comparison of Dialysis Unit and Home Blood Pressures: An Observational Cohort Study. | Am J Kidney Dis | 2021 |
| 33769493 | Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it. | Cardiovasc Res | 2021 |
| 34214210 | Electrophysiological and ECG Effects of Perhexiline, a Mixed Cardiac Ion Channel Inhibitor, Evaluated in Nonclinical Assays and in Healthy Subjects. | J Clin Pharmacol | 2021 |
| 32500447 | Methodological and Regulatory Considerations for Updated Guidance on the Pressor Effects of Drugs. | Ther Innov Regul Sci | 2020 |
| 30447156 | Assessment of Multi-Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study. | Clin Pharmacol Ther | 2019 |
| 30157676 | Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA Meeting. | Ther Innov Regul Sci | 2019 |
| 30247575 | Cardiovascular Safety During and After Use of Phentermine and Topiramate. | J Clin Endocrinol Metab | 2019 |
| 31600125 | Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms. | Circ Res | 2019 |
| 30907981 | The Potential Role of the J-T<sub>peak</sub> Interval in Proarrhythmic Cardiac Safety: Current State of the Science From the American College of Clinical Pharmacology and the Cardiac Safety Research Consortium. | J Clin Pharmacol | 2019 |
| 29212839 | BP in Dialysis: Results of a Pilot Study. | J Am Soc Nephrol | 2018 |
| 30049309 | Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm. | J Am Coll Cardiol | 2018 |
| 30185467 | In-Center Hemodialysis: Time for a Paradigm Shift. | J Am Soc Nephrol | 2018 |
| 29989050 | Prevalence of CKD, Diabetes, and Hypertension in Rural Tanzania. | Kidney Int Rep | 2018 |
| 29870977 | Association of Intradialytic Hypertension with Left Ventricular Mass in Hypertensive Hemodialysis Patients Enrolled in the Blood Pressure in Dialysis (BID) Study. | Kidney Blood Press Res | 2018 |
| 29782553 | Correction: Electrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current Block. | PLoS One | 2018 |
| 29754667 | Is there a role for pharmacokinetic/pharmacodynamic-guided dosing for novel oral anticoagulants? | Am Heart J | 2018 |
| 29672845 | Drug-induced Proarrhythmia and Torsade de Pointes: A Primer for Students and Practitioners of Medicine and Pharmacy. | J Clin Pharmacol | 2018 |
| 29497863 | Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology? | Curr Diab Rep | 2018 |
| 29603015 | Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignancies. | Cancer Chemother Pharmacol | 2018 |
| 29209907 | Scientific white paper on concentration-QTc modeling. | J Pharmacokinet Pharmacodyn | 2018 |
| 29330761 | Correction to: Scientific white paper on concentration-QTc modeling. | J Pharmacokinet Pharmacodyn | 2018 |
| 28986934 | Mechanistic Model-Informed Proarrhythmic Risk Assessment of Drugs: Review of the "CiPA" Initiative and Design of a Prospective Clinical Validation Study. | Clin Pharmacol Ther | 2018 |
| 27798210 | Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects. | J Antimicrob Chemother | 2017 |
| 28407875 | Mendelian randomization to establish the causality of uric acid with diabetic nephropathy in type 1 diabetics. | Kidney Int | 2017 |
| 28454799 | Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium. | Am Heart J | 2017 |
| 28151871 | Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices. | Medicine (Baltimore) | 2017 |
| 29064178 | Low dialysate potassium concentration is associated with prolonged recovery time. | Hemodial Int | 2017 |
| 28543601 | Influence of Meals and Glycemic Changes on QT Interval Dynamics. | J Clin Pharmacol | 2017 |
| 28543393 | Model-Based Evaluation of Exenatide Effects on the QT Interval in Healthy Subjects Following Continuous IV Infusion. | J Clin Pharmacol | 2017 |
| 26893184 | Evolution of strategies to improve preclinical cardiac safety testing. | Nat Rev Drug Discov | 2016 |
| 27606498 | Intradialytic hypotension. | Curr Opin Nephrol Hypertens | 2016 |
| 28036334 | Electrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current Block. | PLoS One | 2016 |
| 27297854 | The Cardiac Safety Research Consortium enters its second decade: An invitation to participate. | Am Heart J | 2016 |
| 27297852 | NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank. | Am Heart J | 2016 |
| 27142425 | Selecting SNPs informative for African, American Indian and European Ancestry: application to the Family Investigation of Nephropathy and Diabetes (FIND). | BMC Genomics | 2016 |
| 27282641 | The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative - Update on progress. | J Pharmacol Toxicol Methods | 2016 |
| 26776538 | Comparison of Prescribed and Measured Dialysate Sodium: A Quality Improvement Project. | Am J Kidney Dis | 2016 |
| 26912057 | Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events. | Cardiovasc Diabetol | 2016 |
| 25819855 | Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium. | Am Heart J | 2015 |
| 30222452 | Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 Diabetes. | Ther Innov Regul Sci | 2015 |
| 26305897 | Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND). | PLoS Genet | 2015 |
| 26286925 | Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing. | Clin J Am Soc Nephrol | 2015 |
| 26130617 | Satisfaction with Care of Patients on Hemodialysis. | Clin J Am Soc Nephrol | 2015 |
| 26044252 | Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes. | Circ Res | 2015 |
| 26093861 | Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research Consortium. | Am Heart J | 2015 |
| 25914207 | Electrocardiographic effects of class 1 selective histone deacetylase inhibitor romidepsin. | Cancer Med | 2015 |